GGrantIndex
Sort

85,873 grants matching alzheimers

NATIONAL INSTITUTE ON AGING INFORMATION RESOURCE CENTER FOR A PERIOD OF PERFORMANCE FROM DECEMBER 19, 2019 TO SEPTEMBER 15, 2022.

$8,914,660
Tom Brackett · Iq Solutions, Inc. · N02 · FY2021 · DA

Lifecourse health, cerebral pathology and ethnic disparities in dementia

$8,903,742
Rachel A Whitmer · University Of California At Davis · RF1 · FY2016 · AG

A Next Generation Data Infrastructure to Understand Disparities across the Life Course

$8,819,742
Arie Kapteyn · University Of Southern California · U01 · FY2025 · AG

Administrative Core

$8,813,439
Charles Decarli · University Of California At Davis · U19 · FY2021 · NS

Alzheimer's Disease Cooperative Study

$8,803,397
Howard Feldman · University Of California, San Diego · U19 · FY2019 · AG

Genetic Epidemiology of Cerebrovascular Factors in Alzheimer's Disease

$8,800,813
Richard Mayeux · Columbia University Health Sciences · RF1 · FY2016 · AG

Longitudinal multicenter head-to-head harmonization of tau PET tracers

$8,757,538
Tharick Pascoal · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AG

Alzheimer's Disease Neuroimaging Initiative

$8,750,000
Northern California Institute Res &Educ · U01 · FY2004 · AG

Longitudinal multicenter head-to-head harmonization of tau PET tracers

$8,747,908
Tharick Pascoal · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · AG

Alzheimer's Disease Cooperative Study

$8,741,293
Howard Feldman · University Of California, San Diego · U19 · FY2020 · AG

Longevity Consortium

$8,740,512
Nicholas Joseph Schork · Translational Genomics Research Inst · U19 · FY2025 · AG

Combination anti-amyloid therapy for preclinical Alzheimer's disease

$8,732,454
Paul S. Aisen · University Of Southern California · R01 · FY2021 · AG

Combination anti-amyloid therapy for preclinical Alzheimer's disease

$8,727,018
Paul S. Aisen · University Of Southern California · R01 · FY2022 · AG

Interactions of SARS-CoV-2 infection and genetic variation on the risk of cognitive decline and Alzheimer’s disease in Ancestral and Admixed Populations

$8,725,158
Gabriel Alejandro De Erausquin · University Of Texas Hlth Science Center · U19 · FY2023 · AG

Combination anti-amyloid therapy for preclinical Alzheimer's disease

$8,723,068
Paul S. Aisen · University Of Southern California · R01 · FY2023 · AG

Combination anti-amyloid therapy for preclinical Alzheimer's disease

$8,720,510
Paul S. Aisen · University Of Southern California · R01 · FY2024 · AG

Epidemiological Integration of Genetic Variants and Metabolomics Profiles in Washington Heights Columbia Aging Project

$8,710,391
Richard Mayeux · Columbia University Health Sciences · RF1 · FY2020 · AG

The Long Life Family Study

$8,696,811
Michael A Province · Washington University · U19 · FY2023 · AG

Administrative Component

$8,689,457
Michael A Province · Washington University · U19 · FY2023 · AG

The Long Life Family Study

$8,689,457
Michael A Province · Washington University · U19 · FY2023 · AG

Longevity Consortium

$8,688,414
Nicholas Joseph Schork · Translational Genomics Research Inst · U19 · FY2024 · AG

Administrative Core

$8,654,399
Michael W Weiner · Northern California Institute/Res/Edu · U19 · FY2022 · AG

Long-read DNA sequencing of Alzheimers Disease and Related Dementias cases

$8,614,246
Andrew Singleton · National Institute On Aging · ZIA · FY2023 · AG

Interactions of SARS-CoV-2 infection and genetic variation on the risk of cognitive decline and Alzheimer’s disease in Ancestral and Admixed Populations

$8,610,822
Gabriel Alejandro De Erausquin · University Of Texas Hlth Science Center · U19 · FY2024 · AG

Alzheimer's Disease Sequencing Project Phenotype Harmonization Consortium

$8,518,767
Timothy J Hohman · Vanderbilt University Medical Center · U24 · FY2024 · AG